Impact of gestational stress on postpartum endothelial function.
Physiological reports · 2026
Abstract originale
Variable stress (VS) is associated with increased cardiovascular risk, and its effects may be intensified during pregnancy. However, the cardiovascular impacts of VS during pregnancy on maternal health are not yet understood. Thus, the aim of this study was to evaluate the impact of VS during gestation on the endothelial function of Wistar rats in the postpartum period. Pregnant rats were divided into Control (C) and VS groups. Stress protocol was applied during the third week of gestation and lasted 8 days. After the lactation period, thoracic aorta and blood were collected for vascular reactivity assessment and platelet aggregation evaluation. Protein abundance was evaluated by western blot. Mothers who experienced VS had higher levels of corticosterone (p = 0.04), confirming the effectiveness of the model. VS animals showed greater sensitivity (p = 0.05) to phenylephrine and reduced relaxation by acetylcholine (p = 0.048), as well as a lower expression of eNOSpser1177 (p = 0.007) and increased platelet aggregation (p = 0.02). Variable stress at the end of gestation seems to cause alterations in both the vasoconstrictor response and endothelium-dependent vasodilation and may be related to reduced eNOS activation that persists even after lactation.
Parole chiave
Leggi il testo integrale originale
Testo estratto dalla pubblicazione: sono esclusi immagini, media, supplementi e parti soggette a diritti distinti.
Impact of gestational stress on postpartum endothelial function
Abstract
Variable stress (VS) is associated with increased cardiovascular risk, and its effects may be intensified during pregnancy. However, the cardiovascular impacts of VS during pregnancy on maternal health are not yet understood. Thus, the aim of this study was to evaluate the impact of VS during gestation on the endothelial function of Wistar rats in the postpartum period. Pregnant rats were divided into Control (C) and VS groups. Stress protocol was applied during the third week of gestation and lasted 8 days. After the lactation period, thoracic aorta and blood were collected for vascular reactivity assessment and platelet aggregation evaluation. Protein abundance was evaluated by western blot. Mothers who experienced VS had higher levels of corticosterone (p = 0.04), confirming the effectiveness of the model. VS animals showed greater sensitivity (p = 0.05) to phenylephrine and reduced relaxation by acetylcholine (p = 0.048), as well as a lower expression of eNOSpser1177 (p = 0.007) and increased platelet aggregation (p = 0.02). Variable stress at the end of gestation seems to cause alterations in both the vasoconstrictor response and endothelium‐dependent vasodilation and may be related to reduced eNOS activation that persists even after lactation.
Keywords: oxidative stress, platelet aggregation, pregnancy, variable stress, vascular function
Gestational variable stress induces persistent maternal vascular dysfunction after lactation, characterized by increased vascular sensitivity to phenylephrine, impaired endothelium‐dependent relaxation, reduced activated eNOS, and enhanced platelet aggregation.
1.INTRODUCTION
Stress can be defined as a natural physiological response of the body to internal or external stimuli, acting as an adaptive mechanism necessary for coping with new situations. Although acute stress responses may exert protective effects in the short term, chronic exposure to one or more stressors can lead to long‐term detrimental health consequences (Rohleder, 2019).
Exposure to psychosocial stress has been associated with adverse health outcomes and an increased risk for the development of several diseases, including cardiovascular disease (CVD), insulin resistance, and cancer (Osborne et al., 2020). The positive association between stress and cardiovascular conditions has become so well established that the European Guidelines for the Prevention of Cardiovascular Diseases consider stress as an additional risk factor for individuals who already present a high risk of cardiovascular events and for those with previously diagnosed CVD (Piepoli et al., 2016).
Stress can exert deleterious effects throughout life; however, during pregnancy these repercussions may be even more pronounced. Pregnancy is characterized by profound physiological, hormonal, and cardiovascular adaptations, and the exacerbation of stress responses during this period may negatively affect both maternal and offspring health. Psychosocial, environmental, and cultural stressors during pregnancy have been shown to induce harmful effects in women and may even promote changes that persist across generations (Coussons‐Read, 2013).
In addition to neuroendocrine and autonomic changes, pregnancy represents a physiological state of high metabolic and vascular demand, in which there is a basal increase in the production of reactive oxygen species. When associated with exposure to variable stress, this scenario can favor an imbalance between pro‐oxidant and antioxidant mechanisms, culminating in exacerbated oxidative stress (Eick et al., 2018). This process is closely related to endothelial dysfunction and platelet aggregation (Ruggeri, 2002), reduced nitric oxide (NO) bioavailability, and alterations in vascular reactivity, promoting changes in tone, resistance, and blood flow (Hammadah et al., 2018).
Despite these findings, the mechanisms by which gestational stress affects maternal physiology remain incompletely understood. Stress has already been associated with increased oxidative stress biomarkers (Eick et al., 2018); however, few investigations have evaluated these effects during pregnancy and in the postpartum period.
Considering that stress is an important risk factor for the development and progression of CVD, it is believed that its impact on vascular function could be even higher during pregnancy. Therefore, the present study aimed to determine the impact of gestational variable stress on postpartum vascular function of Wistar rats.
2.MATERIALS AND METHODS
2.1.Ethics committee
This study was approved by the Ethics Committee on the Use of Animals of the Fluminense Federal University (9518170621) and is in accordance with the standards of the National Council for the control of animal experimentation.
2.2.Animals
Rattus novergicus, albinus variety, Wistar lineage from the LABORATORY ANIMAL CENTER of the FLUMINENSE FEDERAL UNIVERSITY (NAL/UFF) were used. During the entire experimental period, the animals were kept in polypropylene cages, in the vivarium of the UFF BIOMEDICAL INSTITUTE, in a temperature‐controlled environment (24°C ± 2°C) and adequate lighting (light and dark cycle every 12 h).
For mating, 90‐day‐old female rats were placed in collective polypropylene cages in a proportion of two females for each male. After confirmation of pregnancy using the vaginal lavage technique or the presence of a vaginal plug, pregnant females were separated into individual cages and divided into 2 groups: control and variable stress (VS). The females in the stress group performed the variable stress protocol during the third week of pregnancy (14th to the 21st gestational day), as shown in Figure 1.
After the birth of the offspring, both study groups were monitored for the next 21 days, until the end of lactation, and were then euthanized by exsanguination via cardiac puncture. Pregnant rats received standard commercial food (NUVILAB® CR–formulated for rodents), provided by NAL/UFF and water ad libitum.
2.3.Stress protocol
Once the pregnancy was confirmed, the rats in the stress group were subjected daily to a VS protocol (Lucchetti et al., 2026; Martins et al., 2025; Mentzinger et al., 2024) during the third week of gestation, from the 14th to the 21st day of gestation. The protocol consisted of 4 different stimuli performed twice each, non‐consecutively (Table 1).
TABLE 1Variable stress (VS) protocol.
Day Stress type
1 Isolation for 60 min
2 Wet sawdust for 24 h (250 mL of tap water)
3 Cage tilt (5 cm) for 24 h
4 Deprivation of food and water for 6 h (from 3 pm to 9 pm)
5 Isolation for 60 min
6 Wet sawdust for 24 h (250 mL of tap water)
7 Cage tilt (5 cm) for 24 h
8 Deprivation of food and water for 6 h (from 3 pm to 9 pm)
2.4.Body mass
From T0 onwards, the weight of all rats was monitored individually, and food consumption was measured per cage using an electronic digital scale (FILIZOLA®). The change in body mass (delta) was calculated considering the final body mass (g) minus the pre‐gestational body mass (g).
2.5.Euthanasia and sample collection
For blood collection, the animals were fasted for 6 h, anesthetized with Ketamine (40 mg/kg) (VIRBAC LABORATORY S.A.®, São Paulo, Brazil) and Xylazine (8 mg/kg) (VIRBAC LABORATORY S.A.®, São Paulo, Brazil) and underwent metopubic incision with subsequent opening of the thoracic and abdominal cavities. Then, the blood was collected by cardiac puncture and divided into two tubes: one tube without anticoagulant to acquire serum (biochemical analysis) and one tube containing citrate to acquire plasma for platelet aggregation. To obtain plasma, the blood was centrifuged at 3.500 rpm and 4°C for 15 min (SIGMA® centrifuge), which was stored in an ultrafreezer (−80°C) for subsequent biochemical analysis. A portion of the animals from both groups had the thoracic aorta removed for vascular reactivity tests and the other portion had the aorta removed, dissected and stored in an ultrafreezer. Additionally, inguinal fat was weighed to represent subcutaneous tissue and gonadal and retroperitoneal fat to represent visceral tissue.
2.6.Corticosterone levels
To confirm the stress protocol effectiveness, blood samples collected on the day of the mother's euthanasia were separated for measurement of corticosterone levels by chemiluminescence (Corticosterone ELISA Kit, Item N°501320, Cayman).
2.7.Assessment of ex vivo platelet aggregation
Blood samples were collected by cardiac puncture into tubes containing a 3.8% trisodium citrate (9:1 v/v) solution. The platelet‐rich plasma (PRP) was prepared by centrifugation at 250 × g for 10 min at room temperature. The platelet‐poor plasma (PPP) was prepared by centrifugation of the pellet at 1500 × g for 10 min at room temperature. Platelet aggregation was monitored by the turbidimetric method, using a platelet lumi‐aggregometer (MODEL 560CA; CHRONO‐LOG CORPORATION, Havertown, PA, USA). Briefly, this method consists of platelet aggregation monitoring through transmittance. A light beam, with a wavelength equal to 240 nm, crosses the platelet suspension. The aggregometer is calibrated to the PRP corresponds to 0% transmittance and PPP corresponds to 100% transmittance. When the platelets are resting (discoid form), the platelet suspension is opaque, and the transmittance is 0%. At the time of platelet aggregation, the aggregates are formed and the light passes through the platelet suspension, quantitatively increasing the transmittance, which is proportional to the aggregation process. The platelet‐rich plasma (300 μL) was incubated at 37°C for 1 min with continuous stirring at 160 × g, and platelet aggregation was induced by ADP (0.5 μM). Platelet aggregation was expressed as the percentage of aggregation in response to ADP.
2.8.Vascular reactivity
The thoracic aortas were dissected and prepared for isometric tension recording. The aortas were placed in freshly prepared Krebs solution containing 119.0 mM NaCl, 14.9 mM NaHCO3, 11.5 mM glucose, 4.7 mM KCl, 4.2 mM KH2PO4, 1.2 mM MgSO4, and 1.6 mM CaCl2. The aortas were cleaned of all adherent tissue and cut into rings of approximately 3–5 mm. Each ring was suspended between two wire hooks, mounted in 10‐mL organ chambers with Krebs solution at 37°C, pH 7.4 and continuously aerated with a mixture of 95% O2 and 5% CO2 under a resting tension of 1 g. The isometric tension of the tissues was recorded by a force‐displacement transducer (INSIGHT, Brazil) connected to the software (WINDAQ DATA ACQUISITION – DATAQ INSTRUMENTS). After a stabilization period of 60–90 min, the intact endothelium aortic rings were pre‐contracted with phenylephrine (1 μM). Subsequently, the cumulative concentration–response curves to acetylcholine (ACh, 10−9–10−4 M) were obtained for the aortic rings. The relaxation curves were expressed as the percent change from the contraction induced by phenylephrine. The cumulative concentration–response curves to phenylephrine were also determined (10−9–10−4 M). Phenylephrine hydrochloride (CAS No: P6126), and acetylcholine chloride (CAS No: A6625) were purchased from Sigma Aldrich (St Louis, MO, USA). Data were expressed as maximum performance and verified by non‐linear regression using GRAPHPAD PRISM® 8.0.2 SOFTWARE (GraphPad Prism Software Inc., San Diego, CA).
2.9.Biochemical analyses
Capillary blood glucose was determined using a glucometer (ACCU CHEK ACTIVE®) with strips that capture the drop of hemoglobin collected through a small cut in the animal's tail. The biochemical evaluation included analysis of serum concentrations of total cholesterol (TC–K083, Bioclin), high density lipoprotein (HDL–K015, Bioclin), and triglycerides (TG–K117, Bioclin), determined with colorimetric kits. The LDL fraction of cholesterol was calculated using the Friedewald formula: [LDL] = (TC – HDL) – (TG/5). The systemic antioxidant profile was evaluated by measuring the activity of catalase (CAT–Catalase Assay Kit, n°707002, Cayman) and superoxide dismutase (SOD–Superoxide Dismutase Assay Kit, n°706002, Cayman) through radioimmunoassay.
2.10.Protein abundance – Western blot
The thoracic aorta was homogenized with lysis buffer containing protease and phosphatase inhibitors (Pierce™ Protease and Phosphatase Inhibitor Mini Tablets, ref.A32959, Thermo Scientific), for subsequent quantification of protein concentration using an albumin kit (Pierce™, BCA Protein Assay ref.23225, Thermo Scientific). 30 μg of protein was prepared for each tissue in sample buffer for application in a polyacrylamide gel, in which they were separated according to their molecular weight by electrophoresis and transferred from the gel to the polyvinylene fluoride membrane (PVDF – Transfer Membrane, ref.88518, Thermo Scientific), previously blocked with 3% bovine serum albumin (BSA–Bovine Serum Albumin, A7906, Sigma‐Aldrich). Then incubated overnight at 4°C with the specific primary antibodies eNOS (nitric oxide synthase) (eNOS–1:250; sc‐376751, Santa Cruz), eNOSp (phosphorylated nitric oxide synthase) (p‐eNOSSer1177–1:250; ab75639, Abcam) and glutathione peroxidase (GPx–ab226004; 1:500 Abcam). Binding of primary antibodies was detected using secondary antibodies (Mouse anti‐rabbit IgG‐HRP, 1:5000, sc‐2357, Santa Cruz; Mouse IgGκ‐HRP, 1:5000, sc‐516102, Santa Cruz) and ECL (Clarity™ Western ECL Substrate; 170506; Bio‐Rad), reagents for Western Blot. The intensity of the chemiluminescent bands was quantified by densitometric analysis using ImageJ software (IMAGEJ 1.48, NATIONAL INSTITUTES OF HEALTH, USA) and the results were normalized to the expression of the endogenous control protein β‐actin (1:500; sc‐47778, Santa Cruz).
2.11.Statistical analysis
Results were expressed as mean ± standard deviation (SD). Data were assessed for normality using the Shapiro–Wilk test. For comparisons between groups that did not have a normal distribution, the Mann–Whitney test was used. For results with a normal distribution, the unpaired t‐test was used. Two‐way ANOVA was used to analyze the concentration‐response curve between groups with Tukey's post‐test. Results with p ≤ 0.05 were considered significant. GraphPad Prism software version 8.0 was used for these analyses.
3.RESULTS
3.1.Results of the offspring
Regarding litter size, control dams presented an average of 9.00 ± 0.71 pups per litter, whereas stressed dams presented 9.64 ± 1.86 pups per litter. No significant difference was observed between groups (p = 0.48). Control litters comprised 44.4% males and 40% females, while stressed litters comprised 55.6% males and 60% females. No differences in sex ratio were detected between groups (p = 0.85).
Concerning the birth weight of the female offspring, the group whose mother was subjected to the stress protocol had a lower birth weight (6.36 ± 0.24 g; p = 0.0002) when compared to the control group (6.79 ± 0.08 g). Male puppies showed the same behavior with the offspring of the mother who underwent stress, having a lower birth weight (6.61 ± 0.10 g; p = 0.0014) than the animals of the control mothers (7.09 ± 0.32 g).
3.2.Corticosterone
Mothers who underwent the stress protocol showed higher circulating corticosterone concentrations (3.38 ± 1.18 ng/mL) compared to control mothers (1.50 ± 0.35 ng/mL) (p = 0.04), confirming the effectiveness of stress.
3.3.Body mass gain
The group of mothers subjected to VS showed greater weight gain (VS = 45.94 ± 6.68 g; C = 33.89 ± 4.40 g; p = 0.002) from the beginning of pregnancy until the post‐lactation period (Figure 1).
3.4.Food consumption and caloric intake
Both groups presented similar food intake (Table 2). As expected, caloric consumption followed the same pattern.
TABLE 2Food (g) and caloric (kcal) consumption during pregnancy.
Control Variable stress p value
Food consumption (g) 461.13 ± 38.35 454.78 ± 28.65 0.73
Caloric consumption (kcal) 1549.30 ± 128.87 1528.10 ± 96.26
Note: Food (g) and caloric (kcal) intake during the gestational period in rats subjected to the variable stress protocol (Stress) or not subjected to the protocol (Control). Data are presented as mean ± standard deviation.
3.5.Plasma glucose
Glucose values, immediately after the stress protocol, were lower in the VS group (74.57 ± 8.81 mg/dL) when compared to the C group (84.00 ± 4.28 mg/dL, p = 0.03) (Figure 2a). At the end of the experiment (post lactation, Figure 2b), capillary blood glucose values were similar (p = 0.74) between the C (102.00 ± 5.83 mg/dL) and VS (100.30 ± 12.26 mg/dL) groups.
3.6.Lipid profile
Table 3 presents the lipid profile values (total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides) of the C and VS groups. It can be observed that HDL cholesterol was lower in the VS group than the C group. There were no differences in other lipid fractions between the C and VS groups.
TABLE 3Lipid profile of the experimental groups at the end of the experiment.
Control Variable stress p value
Total cholesterol (mg/dL) 110.80 ± 29.11 103.50 ± 43.42 0.74
LDL cholesterol (mg/dL) 43.45 ± 21.46 55.63 ± 40.94 0.53
HDL cholesterol (mg/dL) 48.95 ± 7.87 35.02 ± 7.27 0.01
Triglycerides (mg/dL) 85.08 ± 54.11 65.45 ± 25.06 0.32
Note: Data expressed as mean ± standard deviation.
Abbreviations: HDL, high density lipoproteins; LDL, low density lipoproteins.
3.7.Vascular reactivity
The contractile response to phenylephrine in thoracic aortic rings is shown in Figure 3. The VS group exhibited increased sensitivity to phenylephrine (p = 0.05), as demonstrated by a significantly higher pEC50 value (Figure 3d). This finding is consistent with the results of the concentration–response curve (Figure 3c), indicating vascular hyperreactivity (VS Group pEC50: 7.17 ± 0.19) when compared to C group (pEC50 = 6.47 ± 0.23).
Regarding the endothelium‐dependent vascular relaxation induced by acetylcholine (Figure 3a), maximal relaxation (Figure 3b) was significantly reduced (p = 0.048) in mothers subjected to VS (78.79% ± 17.44%) compared with the control group (104.0% ± 21.28%), representing a 25.21% decrease in the maximal relaxation response.
3.8.Platelet aggregation
Figure 4 demonstrates platelet aggregation values for different concentrations of ADP (adenosine diphosphate). At 0.5 μM concentration, the VS group (47.40% ± 6.78%) showed a higher percentage of platelet aggregation (p = 0.02) when compared to the C group (43.00% ± 10.43%).
3.9.Plasma antioxidant stress markers
Plasma levels of oxidative stress biomarkers are presented in Figure 5. No differences were observed in SOD activity (C = 6.82 ± 0.55 U/mL, VS = 6.81 ± 0.81 U/mL; p = 0.9880; 6A) and CAT activity (C = 10.41 ± 5.50 nmol/min/ml; VS = 9.61 ± 3 0.88 nmol/min/ml; p = 0.7586; 6B) between groups.
3.10.Expression of endothelial nitric oxide and antioxidant protein in vascular tissue
There was no difference in the expression levels of total eNOS (C: 1.00 ± 0.12; VS: 2.83 ± 2.29; p = 0.43–Figure 6a), but a lower expression of its active form p‐eNOS was observed; (Figure 6b) in the VS group (0.66 ± 0.33 AU) when compared to the C group (1.20 ± 0.50 AU, p = 0.007). No difference was observed in the expression of the antioxidant enzyme GPx (C: 1.00 ± 0.50; VS: 0.67 ± 0.33; p = 0.16–Figure 6c) between groups, however, lower CAT expression (C: 1.00 ± 0.87; VS: 0.17 ± 0.12; p = 0.02–Figure 6d) and a trend toward reduced SOD expression (C: 1.00 ± 0.76; VS: 0.25 ± 0.19; p = 0.06–Figure 6e) were observed in the VS group. Representative bands of protein expression in the thoracic aorta, and molecular weight and migration position of marker ladder protein in Figure 6f.
4.DISCUSSION
This study demonstrated that exposure to stress during the final period of gestation was associated with significant endocrine, metabolic, vascular, and hemostatic alterations in females. These alterations included increased corticosterone levels, greater gestational weight gain, reduced HDL cholesterol concentrations, reduced endothelial vasodilation and vasoconstrictor hyperreactivity, increased platelet aggregation, and decreased expression of the active form of eNOS and CAT. Together, these findings indicate that maternal stress affects multiple physiological systems involved in cardiovascular homeostasis.
The corticosterone levels of the animals subjected to the variable stress protocol were elevated when compared to the control group, confirming the effectiveness of the stress protocol. It is already well described in the literature that psychosocial stress can be the trigger for a series of neuroendocrine effects that culminate in changes that increase the risk of cardiovascular disease, such as increased body adiposity, mainly abdominal and visceral fat, insulin resistance and hyperinsulinemia (Lucchetti et al., 2026; Morera et al., 2019).
The greatest weight gain observed in the VS group was not accompanied by increased food intake and caloric consumption, suggesting that exposure to stress influenced the energy balance of these animals. Evidence from a previous review suggests that prolonged exposure to stressful stimuli may result in persistent disturbances in energy homeostasis, which may be detrimental and contribute to the development of metabolic disorders, including increased body weight gain (Patterson & Abizaid, 2013). Besides, psychosocial stress during pregnancy has been routinely studied for its potential association with eating behavior and/or changes in body weight; however, the results for these associations during pregnancy have been inconsistent for several reasons, including the varied stress protocols used and individual variability in gestational weight gain (Braig et al., 2020). Interestingly, exposure to stress resulted in lower blood glucose levels at the end of gestation. However, at the end of the experiment, blood glucose levels were similar between the groups. The greater production of glucocorticoids driven by the stress protocol can promote gluconeogenesis and reduce glucose uptake in adipose tissue, antagonizing the insulin response. Thus, it would be expected to increase plasma glucose and insulin in response to stress (Kuo et al., 2015). However, Quiroga et al. (2021) argue that disorders in glucose metabolism are influenced by several factors, such as the type of rodent used (rat or mouse), genetic history, type of breeding (cross or inbreeding), and the type of stress protocol used (Quiroga et al., 2021).
In contrast to glycemic levels, which became similar between the groups at the end of the experiment, HDL‐cholesterol levels were reduced in the females exposed to stress at the end of the protocol. Dyslipidemia can be caused by genetic predisposition (hereditary dyslipidemia) and other diseases, but the main modulator of lipid metabolism is lifestyle, including the consumption of a diet rich in saturated fats and simple carbohydrates, sedentary lifestyle, smoking, and stress (Francula‐Zaninovic & Nola, 2018). There are no studies available in the literature that evaluate the lipid profile of pregnant rats submitted to a VS protocol; however, in male rats, it was demonstrated that different types of stress (VS, immobilization, and restraint) are involved in the decrease in HDL‐cholesterol (Devaki et al., 2013), meaning this is probably a multi‐mechanism process involving SNS, lifestyle, and oxidative pathways, all of which are closely associated with impaired vascular reactivity (Xia & Li, 2018).
Vascular tone is maintained by the perfect balance between vasodilation and vasoconstriction, being extremely important for cardiovascular homeostasis. Impairments in the balance of this tone can increase the risk of developing CVD (Iring et al., 2019). The present results showed that the thoracic aorta of rats subjected to stress was more sensitive to α‐adrenergic vasoconstriction, an important autonomic response of the organism to specific stimuli, such as severe hypothermia and hemorrhage (Iring et al., 2019).
Some of the pathways involved in the deterioration of vascular function caused by stress have already been discussed such as an intense activation of the SNS that stimulates the production of catecholamines (norepinephrine and epinephrine) responsible for activating α adrenergic receptors, thus stimulating vasoconstriction (Kim et al., 2018). Impairments in the turnover of endothelial cells in the thoracic aorta and coronary arteries, decreased availability of NO and lower levels of nitric oxide synthase (NOS) mRNA expression (Donato et al., 2009; Osborne et al., 2020).
Additionally, for the first time in the literature, we demonstrated that mothers subjected to variable stress during gestation exhibit impaired endothelium‐dependent endothelial function, evidenced by an approximately 24% reduction in acetylcholine‐stimulated maximum vascular relaxation compared to females not exposed to stress. This finding is particularly relevant, since the literature describes that females have a greater capacity to preserve endothelial function compared to males, mainly due to the vasoprotective effects of estrogen (Brooks et al., 2018).
Estrogen contributes to the maintenance of vascular homeostasis through different mechanisms, including increased expression and activation of eNOS, resulting in greater production and bioavailability of NO. NO plays a fundamental role in the regulation of vascular tone, promoting vasodilation and protection against endothelial dysfunction (Chambliss & Shaul, 2002). In fact, previous studies demonstrate that female rodents have a greater capacity to preserve endothelial function when compared to males, even under stress conditions (Brooks et al., 2018). However, the results of the present study indicate that exposure to VS during late gestation appears to promote persistent alterations in the endothelial response.
In the present study, a decrease in p‐eNOS levels was observed in the VS group, thus impairing endothelium‐dependent vasodilation, corroborating the results of vascular reactivity presented previously. Exposure to stress is associated with impaired endothelial function, primarily due to reduced eNOS activation and/or expression, resulting in lower NO production and bioavailability (Osborne et al., 2020). Persistent activation of the hypothalamic–pituitary–adrenal axis and the sympathetic nervous system promotes increased production of reactive oxygen species (ROS), particularly through the activation of NADPH oxidase. Excess ROS rapidly reacts with NO to form peroxynitrite (ONOO−), reducing NO bioavailability and potentially leading to eNOS uncoupling, a condition in which the enzyme produces superoxide anion instead of NO, thereby perpetuating oxidative stress and endothelial dysfunction (Forstermann & Sessa, 2012). Consequently, there is impaired endothelium‐dependent vasodilation, increased vascular reactivity to vasoconstrictors, and a loss of vascular homeostasis, changes that contribute to the development of cardiovascular diseases (Garcia & Sessa, 2019).
The present study showed a higher percentage of platelet aggregation in the VS group. Several studies have reported that exposure to stress is associated with a prothrombotic state, characterized, among other changes, by increased platelet aggregation in rodents (Matsuhisa et al., 2014; Sandrini et al., 2017). There are no studies available in the literature that relate the effect of stress on coagulation during pregnancy; however, it is known that there is a physiological increase in thromboembolic risk in pregnancy caused by the increase in coagulation factors VII, VIII and X and fibrinogen, while fibrinolysis and protein S activity decrease, resulting in a state of blood hypercoagulation, as a physiological preparation for the hemostasis process during childbirth. The risk is even greater during the postpartum period, with pulmonary embolism being the main cause of maternal death in developed countries (Yoon, 2019). Impaired vasoconstriction, as observed in the present study, associated with a state of hypercoagulability can cause a decrease in venous return and thus facilitate the formation of thrombi (Devis & Knuttinen, 2017).
The increased vascular contractile response, reduced endothelium‐dependent relaxation, and decreased eNOS activation observed in this study may suggest the involvement of mechanisms related to oxidative stress. Exposure to the stress protocol increases the production of ROS as well as depressing antioxidant defense. Deterioration of redox homeostasis may represent an important mechanism linking psychological stress to increased cardiovascular risk (de Almeida et al., 2020).
In the present study, no significant differences were observed in SOD and CAT activity between the groups. Previous studies observed that these enzymes decrease throughout pregnancy, which may have masked stress impact, since the stressor protocol was carried out during the third trimester of pregnancy (Lekharu et al., 2014; Sharma et al., 2006; Yuksel & Yigit, 2015). However, when the expression of these antioxidant enzymes was assessed in the thoracic aorta, reduced CAT expression and a trend toward lower SOD expression were observed in the VS group. These findings support the notion that stress may induce redox imbalance, leading to increased oxidative stress and compromising vascular integrity (Handy & Loscalzo, 2022; Shaito et al., 2022).
Although the findings of the present study contribute to the understanding of the effects of gestational stress, they should be considered in light of some methodological limitations. The pharmacological inhibition of NOS was not performed, which limits the direct demonstration of the role of NO in the observed vascular effects; however, the increased phosphorylation of eNOS in Ser1177 constitutes evidence of the activation of this pathway, consistent with the vascular functional findings.
The findings of this work are highly relevant scientifically, since most studies investigating the effects of insults occurring during pregnancy focus predominantly on the offspring, while maternal repercussions remain poorly explored. In this context, our results show, originally, that exposure to stress during pregnancy promotes persistent vascular alterations, characterized by impaired endothelial function and vascular hyperreactivity. In addition to expanding knowledge about the maternal consequences of stress during pregnancy, this study provides support for future investigations of the molecular mechanisms involved in these alterations. The results also open perspectives for the development of preventive and therapeutic strategies aimed at minimizing the observed vascular damage and potentially reducing the progression to cardiovascular diseases throughout life.
5.CONCLUSION
This study demonstrates that exposure to variable stress at the end of gestation causes persistent alterations in vascular reactivity, observed even after the lactation period. These alterations affect both the vasoconstrictor response and endothelium‐dependent vasodilation and may be related to reduced eNOS activation and the presence of platelet aggregation in animals subjected to gestational stress.
AUTHOR CONTRIBUTIONS
Pedro Ribeiro de Souza: Data curation; investigation; methodology. Juliana Arruda de Souza Monnerat: Conceptualization; data curation; investigation; methodology. Bianca Bittencourt Luchetti: Investigation; methodology. Juliana Mentzinger: Methodology. Gabriel Fernandes Teixeira: Data curation; investigation; methodology; project administration. Helena Naly Miguens Rocha: Data curation; investigation; methodology. Fernanda Carla Ferreira de Brito: Data curation; methodology; validation. Nadia Alice Vieira da Motta: Methodology; project administration. Gabriel Ferreira Lima: Methodology. Anna Caldas Manhães: Formal analysis. Vinicius Nogueira Macedo: Visualization. Natalia Galito Rocha: Conceptualization; data curation; formal analysis; funding acquisition; methodology; supervision. Antonio Claudio Lucas da Nóbrega: Conceptualization; resources; supervision. Renata Frauches Medeiros: Conceptualization; data curation; formal analysis; funding acquisition; investigation; methodology; project administration; resources; supervision.
FUNDING INFORMATION
This study was supported by grants from the Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro (FAPERJ; E‐26/204.214/2025) and the Coordination for the Improvement of Higher Education Personnel (CAPES).
CONFLICT OF INTEREST STATEMENT
The authors report no conflicts of interest.
ETHICS STATEMENT
All animal procedures were approved by the Animal Ethics Committee of Fluminense Federal University under protocol number (9518170621) and were conducted in accordance with national and institutional guidelines for the care and use of laboratory animals.
ACKNOWLEDGMENTS
This work was developed within the framework of the National Institute of Science and Technology – INCT Physical (In)activity and Health (CNPq, Brazil). The authors thank the members of the Exercise Science Laboratory (Laboratório de Ciências do Exercício – LACE), the Experimental Pharmacology Laboratory (Laboratório de Farmacologia Experimental – LAFE), the vivarium technicians of the Biomedical Institute at Fluminense Federal University (UFF), and the staff of the Multiuser Laboratory of Physiology and Pharmacology (Laboratório Multiusuários de Fisiologia e Farmacologia – LAMFFA) for their technical assistance and support.
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are available from the corresponding author upon reasonable request.
REFERENCES
Braig, S.
,
Logan, C. A.
,
Reister, F.
,
Rothenbacher, D.
, &
Genuneit, J.
(2020). Psychosocial stress and longitudinally measured gestational weight gain throughout pregnancy: The Ulm SPATZ health study. Scientific Reports, 10(1), 1996. 10.1038/s41598-020-58808-8
Brooks, S. D.
,
Hileman, S. M.
,
Chantler, P. D.
,
Milde, S. A.
,
Lemaster, K. A.
,
Frisbee, S. J.
,
Shoemaker, J. K.
,
Jackson, D. N.
, &
Frisbee, J. C.
(2018). Protection from vascular dysfunction in female rats with chronic stress and depressive symptoms. American Journal of Physiology. Heart and Circulatory Physiology, 314(5), H1070–H1084. 10.1152/ajpheart.00647.2017
Chambliss, K. L.
, &
Shaul, P. W.
(2002). Estrogen modulation of endothelial nitric oxide synthase. Endocrine Reviews, 23(5), 665–686. 10.1210/er.2001-0045
Coussons‐Read, M. E.
(2013). Effects of prenatal stress on pregnancy and human development: Mechanisms and pathways. Obstet Med, 6(2), 52–57. 10.1177/1753495X12473751
de Almeida, A.
,
de Almeida Rezende, M. S.
,
Dantas, S. H.
,
de Lima Silva, S.
,
de Oliveira, J.
,
de Lourdes Assuncao Araujo de Azevedo, F.
,
Alves, R. M. F. R.
,
de Menezes, G. M. S.
,
Dos Santos, P. F.
,
Gonçalves, T. A. F.
,
Schini‐Kerth, V. B.
, &
de Medeiros, I. A.
(2020). Unveiling the role of inflammation and oxidative stress on age‐related cardiovascular diseases. Oxidative Medicine and Cellular Longevity, 2020, 1954398. 10.1155/2020/1954398
Devaki, M.
,
Nirupama, R.
, &
Yajurvedi, H. N.
(2013). Chronic stress‐induced oxidative damage and hyperlipidemia are accompanied by atherosclerotic development in rats. Stress, 16(2), 233–243. 10.3109/10253890.2012.719052
Devis, P.
, &
Knuttinen, M. G.
(2017). Deep venous thrombosis in pregnancy: Incidence, pathogenesis and endovascular management. Cardiovascular Diagnosis and Therapy, 7(Suppl 3), S309–S319. 10.21037/cdt.2017.10.08
Donato, A. J.
,
Gano, L. B.
,
Eskurza, I.
,
Silver, A. E.
,
Gates, P. E.
,
Jablonski, K.
, &
Seals, D. R.
(2009). Vascular endothelial dysfunction with aging: Endothelin‐1 and endothelial nitric oxide synthase. American Journal of Physiology. Heart and Circulatory Physiology, 297(1), H425–H432. 10.1152/ajpheart.00689.2008
Eick, S. M.
,
Barrett, E. S.
,
van't Erve, T. J.
,
Nguyen, R. H. N.
,
Bush, N. R.
,
Milne, G.
,
Swan, S. H.
, &
Ferguson, K. K.
(2018). Association between prenatal psychological stress and oxidative stress during pregnancy. Paediatric and Perinatal Epidemiology, 32(4), 318–326. 10.1111/ppe.12465
Forstermann, U.
, &
Sessa, W. C.
(2012). Nitric oxide synthases: Regulation and function. European Heart Journal, 33(7), 829–837, 837a‐837d. 10.1093/eurheartj/ehr304
Francula‐Zaninovic, S.
, &
Nola, I. A.
(2018). Management of Measurable Variable Cardiovascular Disease' risk factors. Current Cardiology Reviews, 14(3), 153–163. 10.2174/1573403X14666180222102312
Garcia, V.
, &
Sessa, W. C.
(2019). Endothelial NOS: Perspective and recent developments. British Journal of Pharmacology, 176(2), 189–196. 10.1111/bph.14522
Hammadah, M.
,
Kim, J. H.
,
Al Mheid, I.
,
Samman Tahhan, A.
,
Wilmot, K.
,
Ramadan, R.
,
Alkhoder, A.
,
Khayata, M.
,
Mekonnen, G.
,
Levantsevych, O.
,
Bouchi, Y.
,
Kaseer, B.
,
Choudhary, F.
,
Gafeer, M. M.
,
Corrigan, F. E., 3rd
,
Shah, A. J.
,
Ward, L.
,
Kutner, M.
,
Bremner, J. D.
, …
Quyyumi, A. A.
(2018). Coronary and peripheral vasomotor responses to mental stress. Journal of the American Heart Association, 7(10), e008532. 10.1161/JAHA.118.008532
Handy, D. E.
, &
Loscalzo, J.
(2022). The role of glutathione peroxidase‐1 in health and disease. Free Radical Biology & Medicine, 188, 146–161. 10.1016/j.freeradbiomed.2022.06.004
Iring, A.
,
Jin, Y. J.
,
Albarran‐Juarez, J.
,
Siragusa, M.
,
Wang, S.
,
Dancs, P. T.
,
Nakayama, A.
,
Tonack, S.
,
Chen, M.
,
Künne, C.
,
Sokol, A. M.
,
Günther, S.
,
Martínez, A.
,
Fleming, I.
,
Wettschureck, N.
,
Graumann, J.
,
Weinstein, L. S.
, &
Offermanns, S.
(2019). Shear stress‐induced endothelial adrenomedullin signaling regulates vascular tone and blood pressure. Journal of Clinical Investigation, 129(7), 2775–2791. 10.1172/JCI123825
Kim, H. G.
,
Cheon, E. J.
,
Bai, D. S.
,
Lee, Y. H.
, &
Koo, B. H.
(2018). Stress and heart rate variability: A meta‐analysis and review of the literature. Psychiatry Investigation, 15(3), 235–245. 10.30773/pi.2017.08.17
Kuo, T.
,
McQueen, A.
,
Chen, T. C.
, &
Wang, J. C.
(2015). Regulation of glucose homeostasis by glucocorticoids. Advances in Experimental Medicine and Biology, 872, 99–126. 10.1007/978-1-4939-2895-8_5
Lekharu, R.
,
Pradhan, R.
,
Sharma, R.
, &
Sharma, D.
(2014). A study of lipid peroxidation and antioxidant enzymes in Normal pregnancy. Journal of Medical Sciences, 3(1), 55–56.
Lucchetti, B. B.
,
Monnerat, J. A. S.
,
Teixeira, G. F.
,
Mentzinger, J.
,
Rocha, L.
,
Rocha, H. N. M.
,
Nóbrega, A. C. L. D.
, &
Medeiros, R. F.
(2026). Aerobic training prevents the stress‐induced endothelial dysfunction in male and female Wistar rats by different pathways. Journal of Applied Physiology (Bethesda, MD: 1985), 141(4), 1135–1146. 10.1152/japplphysiol.01061.2025
Martins, M. A. C.
,
Monnerat, J. A. S.
,
Teixeira, G. F.
,
Lucchetti, B. B.
,
Mentzinger, J.
,
Velasco, L. L.
,
Sodré, F. A.
,
Silva, E. M.
,
Rocha, H. N. M.
,
Nóbrega, A. C. L.
,
Rocha, N. G.
,
Rocha, G. S.
, &
Medeiros, R. F.
(2025). Impact of gestational stress on bone and body composition in Wistar rats after lactation. Brazilian Journal of Medical and Biological Research, 58, e14551. 10.1590/1414-431X2025e14551
Matsuhisa, F.
,
Kitamura, N.
, &
Satoh, E.
(2014). Effects of acute and chronic psychological stress on platelet aggregation in mice. Stress, 17(2), 186–192. 10.3109/10253890.2014.888548
Mentzinger, J.
,
Teixeira, G. F.
,
Monnerat, J. A. S.
,
Velasco, L. L.
,
Lucchetti, B. B.
,
Martins, M. A. C.
,
Costa, V.
,
Andrade, G. P.
,
Magliano, D. C.
,
Rocha, H. N. M.
,
da Nóbrega, A. C. L.
,
Medeiros, R. F.
, &
Rocha, N. G.
(2024). Prenatal stress induces sex‐ and tissue‐specific alterations in insulin pathway of Wistar rats offspring. American Journal of Physiology. Heart and Circulatory Physiology, 327(4), H1055–H1066. 10.1152/ajpheart.00243.2024
Morera, L. P.
,
Marchiori, G. N.
,
Medrano, L. A.
, &
Defago, M. D.
(2019). Stress, dietary patterns and cardiovascular disease: A mini‐review. Frontiers in Neuroscience, 13, 1226. 10.3389/fnins.2019.01226
Osborne, M. T.
,
Shin, L. M.
,
Mehta, N. N.
,
Pitman, R. K.
,
Fayad, Z. A.
, &
Tawakol, A.
(2020). Disentangling the links between psychosocial stress and cardiovascular disease. Circulation. Cardiovascular Imaging, 13(8), e010931. 10.1161/CIRCIMAGING.120.010931
Patterson, Z. R.
, &
Abizaid, A.
(2013). Stress induced obesity: Lessons from rodent models of stress. Frontiers in Neuroscience, 7, 130. 10.3389/fnins.2013.00130
Piepoli, M. F.
,
Hoes, A. W.
,
Agewall, S.
,
Albus, C.
,
Brotons, C.
,
Catapano, A. L.
,
Cooney, M. T.
,
Corrà, U.
,
Cosyns, B.
, &
Monique Verschuren, W. M.
(2016). 2016 European guidelines on cardiovascular disease prevention in clinical practice. Revista Española de Cardiología (English Edition), 69(10), 939. 10.1016/j.rec.2016.09.009
Quiroga, S.
,
Juarez, Y. R.
,
Marcone, M. P.
,
Vidal, M. A.
,
Genaro, A. M.
, &
Burgueno, A. L.
(2021). Prenatal stress promotes insulin resistance without inflammation or obesity in C57BL/6J male mice. Stress, 24(6), 987–997. 10.1080/10253890.2021.1978425
Rohleder, N.
(2019). Stress and inflammation ‐ the need to address the gap in the transition between acute and chronic stress effects. Psychoneuroendocrinology, 105, 164–171. 10.1016/j.psyneuen.2019.02.021
Ruggeri, Z. M.
(2002). Platelets in atherothrombosis. Nature Medicine, 8(11), 1227–1234. 10.1038/nm1102-1227
Sandrini, L.
,
Ieraci, A.
,
Amadio, P.
,
Popoli, M.
,
Tremoli, E.
, &
Barbieri, S. S.
(2017). Apocynin prevents abnormal Megakaryopoiesis and platelet activation induced by chronic stress. Oxidative Medicine and Cellular Longevity, 2017, 9258937. 10.1155/2017/9258937
Shaito, A.
,
Aramouni, K.
,
Assaf, R.
,
Parenti, A.
,
Orekhov, A.
,
Yazbi, A. E.
,
Pintus, G.
, &
Eid, A. H.
(2022). Oxidative stress‐induced endothelial dysfunction in cardiovascular diseases. Frontiers in Bioscience (Landmark Edition), 27(3), 105. 10.31083/j.fbl2703105
Sharma, J. B.
,
Sharma, A.
,
Bahadur, A.
,
Vimala, N.
,
Satyam, A.
, &
Mittal, S.
(2006). Oxidative stress markers and antioxidant levels in normal pregnancy and pre‐eclampsia. International Journal of Gynaecology and Obstetrics, 94(1), 23–27. 10.1016/j.ijgo.2006.03.025
Xia, N.
, &
Li, H.
(2018). Loneliness, social isolation, and cardiovascular health. Antioxidants & Redox Signaling, 28(9), 837–851. 10.1089/ars.2017.7312
Yoon, H. J.
(2019). Coagulation abnormalities and bleeding in pregnancy: An anesthesiologist's perspective. Anesthesia and Pain Medicine (Seoul), 14(4), 371–379. 10.17085/apm.2019.14.4.371
Yuksel, S.
, &
Yigit, A. A.
(2015). Malondialdehyde and nitric oxide levels and catalase, superoxide dismutase, and glutathione peroxidase levels in maternal blood during different trimesters of pregnancy and in the cord blood of newborns. Turkish Journal of Medical Sciences, 45(2), 454–459.
Associated Data
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Come citare questo studio
de Souza PR, de Souza Monnerat JA, Luchetti BB, Mentzinger J, Teixeira GF, Rocha HNM, de Brito FCF, Lima GF, da Motta NAV, Manhães AC, Macedo VN, Rocha NG, da Nóbrega ACL, Medeiros RF. (2026). Impact of gestational stress on postpartum endothelial function.. Physiological reports. DOI: 10.14814/phy2.71171
Consulta la pubblicazione originale ↗